Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Self-reactive B cells in the GALT are actively curtailed to prevent gut inflammation
Ashima Shukla, Cindi Chen, Julia Jellusova, Charlotte R. Leung, Elaine Kao, Numana Bhat, Wai W. Lin, John R. Apgar, Robert C. Rickert
Ashima Shukla, Cindi Chen, Julia Jellusova, Charlotte R. Leung, Elaine Kao, Numana Bhat, Wai W. Lin, John R. Apgar, Robert C. Rickert
View: Text | PDF
Research Article Immunology Inflammation

Self-reactive B cells in the GALT are actively curtailed to prevent gut inflammation

  • Text
  • PDF
Abstract

Immune homeostasis in the gut-associated lymphoid tissues (GALT) is critical to prevent the development of inadvertent pathologies. B cells, as the producers of antibodies and cytokines, play an important role in maintaining the GALT homeostasis. However, the mechanism by which B cells specifically direct their responses toward non-self-antigens and become ignorant to self-antigens in the GALT is not known. Therefore, we developed what we believe to be a novel mouse model by expressing duck egg lysozyme (DEL) in gut epithelial cells in presence of HEL-reactive B cells. Notably, we observed a transient activation and rapid deletion of self-reactive B cells in Peyer’s patches and mesenteric lymph nodes upon self-antigen exposure. The survival of self-reactive B cells upon exposure to their self-antigen was partially rescued by blocking receptor editing but could be completely rescued by stronger survival signal, such as ectopic expression of BCL2. Importantly, rescuing the self-reactive B cells promoted production of autoantibodies and gut inflammation. Mechanistically, we identify a specific activation of TGF-β signaling in self-reactive B cells in the gut and a critical role of this pathway in maintaining peripheral tolerance. Collectively, our studies describe functional consequences and the fate of self-reactive B cells in GALT and provide potentially novel mechanistic insights governing self-tolerance of B cells in the gut.

Authors

Ashima Shukla, Cindi Chen, Julia Jellusova, Charlotte R. Leung, Elaine Kao, Numana Bhat, Wai W. Lin, John R. Apgar, Robert C. Rickert

×

Figure 9

Inhibition of TGF-β signaling rescues self-reactive B cells upon antigen encounter in gut.

Options: View larger image (or click on image) Download as PowerPoint
Inhibition of TGF-β signaling rescues self-reactive B cells upon antigen...
(A) Histogram and graph displaying TGFβRI expression and MFI of TGFβR1 staining in HEL-specific cells from spleens, pLNs, mLNs, and PPs of RVillincre+ (Bcl2) and RVillincre+mDELloxp (Bcl2) mice. (B) Experimental design schematic for study of the role of TGF-β signaling in self-reactive B cells. Gated on B220+, the left column shows the percentage of CFSE+ (non-HEL-specific cells) and right column shows the percentage of eFLuor670+ cells in spleens, pLNs, mLNs, and PPs. (C) Histogram and graph displaying the p-Smad2/3 expression and MFI of p-Smad2/3 staining, as measured by flow cytometry in DMSO- and TGFβI/II R inhibitor–treated HEL-specific cells from spleen, pLNs, mLNs and PPs Villincre+ and Villincre+mDELloxp mice 72 hours after adoptive transfer. Graph of HEL-specific cells treated with DMSO or TGFβI/II R inhibitor in spleens, pLNs, mLNs, and PPs (D) of CD69 MFI and S1PR1 MFI. The statistical analysis was done by paired t test in Prism. ****P < 0.0001, ***P = 0.0002, **P = 0.0077, *P = 0.0105, n = 4 and experiment was repeated 3 times.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts